Associated Papers
SLC26A9 as a Potential Modifier and Therapeutic Target in Cystic Fibrosis Lung Disease.
Gorrieri G et al.
Biomolecules, 2022
Structural insights into the gating mechanism of human SLC26A9 mediated by its C-terminal sequence.
Chi X et al.
Cell Discovery, 2020
Select a paper to view details